Adult Changes in Thought (ACT) Research Program

成人思想变化 (ACT) 研究计划

• 批准号: 10672341
• 负责人: Paul K Crane
• 金额: $ 1106.05万
• 依托单位: KAISER FOUNDATION RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-05-15 至 2026-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10672341
• 关键词: Accelerometer; Adopted; Adult; Affect; Aging; Alzheimer' s Disease; Alzheimer' s disease related dementia; Alzheimer' s disease risk; American; Anti-Cholinergics; Antihypertensive Agents; Autopsy; Behavioral Sciences; Biological Assay; Biological Markers; Biology; Brain; Caregivers; Caring; Cause of Death; Cells; Cholinergic Agents; Clinical; Clinical Data; Clinical Research; Cognition; Cognitive; Cognitive aging; Cohort Studies; Communities; Complex; Conceptions; Consent; Country; Data; Data Set; Dementia; Development; Devices; Diabetes Mellitus; Diagnosis; Discipline; Disease; Ecology; Economics; Elderly; Enrollment; Ethnic Origin; Etiology; Exercise; Family; Foundations; Fright; Funding; Future; Glucose; Goals; Grant; Hour; Human; Image; Impaired cognition; Incidence; Individual; Influentials; Intervention; Investigation; Investments; Learning; Lewy Body Dementia; Life; Life Cycle Stages; MRI Scans; Measures; Mentorship; Methods; Modernization; Movement; National Institute on Aging; Nerve Degeneration; Neurobehavioral Manifestations; Neurons; Outcome; Participant; Persons; Pharmaceutical Preparations; Pharmacoepidemiology; Phenotype; Physical Function; Physical Performance; Physical activity; Policies; Positioning Attribute; Prevalence; Prevention; Process; Prospective Studies; Prospective, cohort study; Race; Recording of previous events; Records; Reproducibility; Research; Research Personnel; Resources; Risk; Risk Factors; Sample Size; Science; Scientist; Senile Plaques; Series; Specimen; Subgroup; System; Toxic effect; Visit; Work; age related; aging brain; clinical care; clinical diagnosis; cognitive function; cognitive performance; cohort; data resource; data sharing; density; design; disorder subtype; epidemiology study; ethnic diversity; follow-up; health care delivery; high risk; human old age (65+); improved; indexing; interoperability; neural; neuroimaging; neuropathology; participant enrollment; physical conditioning; preservation; prevent; programs; prospective; recruit; resilience; resilience factor; sedentary lifestyle; sleep pattern; socioeconomic diversity; stem cells; tissue resource; tool; web site

The Adult Changes in Thought (ACT) U19 Program will expand, modernize, and improve ACT's prospective cohort study to achieve advances in scientific understanding of older adults in general and dementia and Alzheimer's disease in particular. ACT is set in a healthcare delivery system. The study team identifies incident cases of dementia and Alzheimer's disease and follows consenting participants to autopsy. The Program will transform the current ACT U01 to a U19, which envisions complex multi-component programs that will have a powerful influence on the field. The Program's overarching goal is to identify risk factors across the life course that provide potential intervention targets for preserving cognition and preventing Alzheimer's disease and related dementias (ADRD). The Overall Specific Aims are: Aim 1. Expand ACT cohort enrollment and modernize and improve follow-up with emphasis on increasing racial/ethnic diversity and deep phenotyping of life course risk factors, cognitive and physical functioning, and outcomes including neuroimaging and neuropathology based ADRD outcomes. The Cores will expand cohort enrollment from 2,000 to 3,000. The study will invest in six Cores: A, Administrative; B, Clinical; C, Life Course; D, Neuropathology; E, Neuroimaging; F, Data and Analysis. These Cores will work together to further enhance the value of ACT's resources, enabling the ACT study to continue to be the foundation for an extraordinary array of science. To date, ACT has achieved a completeness of follow-up index of 94.5% and has observed 56,140 person-years of follow-up. ACT has identified >1,300 incident dementia cases and >1,000 incident Alzheimer's cases. The study has completed >850 autopsies and will surpass 1,100 autopsies this cycle. Additionally, 1,077 ACT participants had one MRI scan, and 540 have had ≥2, with funding in place for hundreds more. Aim 2. Support key Projects studying the spectrum of healthy functioning to ADRD in older adults. The three Projects center around 24-hour cycle physical activity, sedentary behavior, and sleep patterns in old age (Project 1), the implications of cognitively defined Alzheimer's disease subgroups (Project 2), and mechanisms underlying neural protection and toxicity of strong anticholinergic drugs and antihypertensive drugs (Project 3). Aim 3. Expand and improve ACT's dissemination of exceptional resources to the research community guided by NIA's adopted FAIR (Findable, Accessible, Interoperable, and Reproducible) principles. ACT has proven to be an exceptional resource to the research community, providing data and specimens to research colleagues locally, across the country, and around the world, and provides mentorship to junior investigators. We will continue to enhance our data sharing capabilities in this U19 Program.

成人思想转变 (ACT) U19 计划将扩大、现代化并改善 ACT 的前景 队列研究旨在提高对老年人和痴呆症的科学认识 研究小组特别确定了阿尔茨海默病的发生情况。 该计划将对痴呆症和阿尔茨海默病病例进行尸检，并在同意的参与者之后进行尸检。 将当前的 ACT U01 转变为 U19，它设想了复杂的多组成部分的项目，这些项目将具有 该计划的总体目标是识别整个生命过程中的风险因素。 为保持认知和预防阿尔茨海默病提供潜在的干预目标 相关痴呆症 (ADRD) 的总体具体目标是： 目标 1. 扩大 ACT 队列入学率和 现代化并改进后续行动，重点是增加种族/民族多样性和深层表型 生命历程风险因素、认知和身体功能以及包括神经影像学和神经影像学在内的结果 基于 ADRD 结果的神经病理学将队列注册人数从 2,000 人扩大到 3,000 人。 研究将投资于六个核心：A，管理；B，临床；D，神经病理学； 神经影像；F，数据和分析。这些核心将共同努力，进一步提升 ACT 的价值。 资源，使 ACT 研究能够继续成为一系列非凡科学的基础。 截至目前，ACT 随访指数完成度达 94.5%，已观察到 56,140 人年 ACT 已发现超过 1,300 例痴呆病例和超过 1,000 例阿尔茨海默病病例。 研究已完成超过 850 例尸检，本周期将超过 1,100 例尸检，另外还有 1,077 例 ACT。 参与者接受了 1 次 MRI 扫描，540 人接受了 2 次以上，并为数百人提供了资金支持。目标 2。 研究老年人 ADRD 健康功能范围的关键项目 这三个项目中心。 大约 24 小时周期的体力活动、久坐行为和老年睡眠模式（项目 1）， 认知定义的阿尔茨海默病亚组的影响（项目 2）以及潜在机制 强效抗胆碱能药物和抗高血压药物的神经保护和毒性（项目3）。 在 NIA 的指导下，扩大和改进 ACT 向研究界传播特殊资源的能力 采用的公平（Findable、Accessible、Interoperable 和 Reproducible）原则已被证明是一种 为研究界提供特殊资源，为当地研究同事提供数据和样本， 我们将继续在全国和世界各地为初级研究人员提供指导。 在此 U19 计划中增强我们的数据共享能力。

项目成果

Visual Field Endpoints for Neuroprotective Trials: A Case for AI-Driven Patient Enrichment.

神经保护试验的视野终点：人工智能驱动的患者丰富案例。

• 发表时间: 2022-11
• 影响因子: 4.2
• 作者: Chen, Andrew;Montesano, Giovanni;Lu, Randy;Lee, Cecilia S;Crabb, David P;Lee, Aaron Y
• 通讯作者: Lee, Aaron Y

Traffic-related air pollution and dementia incidence in the Adult Changes in Thought Study.

成人思想变化研究中与交通相关的空气污染和痴呆症发病率。

• 发表时间: 2024-01
• 影响因子: 11.8
• 作者: Blanco, Magali N;Shaffer, Rachel M;Li, Ge;Adar, Sara D;Carone, Marco;Szpiro, Adam A;Kaufman, Joel D;Larson, Timothy V;Hajat, Anjum;Larson, Eric B;Crane, Paul K;Sheppard, Lianne
• 通讯作者: Sheppard, Lianne

Ethnicity is not biology: retinal pigment score to evaluate biological variability from ophthalmic imaging using machine learning.

种族不是生物学：使用机器学习评估眼科成像的生物学变异性的视网膜色素评分。

• 发表时间: 2023-07-06
• 作者: Rajesh, Anand E;Olvera;Warwick, Alasdair N;Wu, Yue;Stuart, Kelsey V;Biradar, Mahantesh;Ung, Chuin Ying;Khawaja, Anthony P;Luben, Robert;Foster, Paul J;Lee, Cecilia S;Tufail, Adnan;Lee, Aaron Y;Egan, Catherine;EPIC Norfolk, U
• 通讯作者: EPIC Norfolk, U

Convolutional neural network-based classification of glaucoma using optic radiation tissue properties.

使用视辐射组织特性进行基于卷积神经网络的青光眼分类。

• 发表时间: 2024-04-11
• 作者: Kruper, John;Richie;Benson, Noah C;Caffarra, Sendy;Owen, Julia;Wu, Yue;Egan, Catherine;Lee, Aaron Y;Lee, Cecilia S;Yeatman, Jason D;Rokem, Ariel;UK Biobank Eye and Vision Consortium
• 通讯作者: UK Biobank Eye and Vision Consortium

Large language models and their impact in ophthalmology.

大型语言模型及其对眼科的影响。

• DOI: 10.1016/s2589-7500(23)00201-7
• 发表时间: 2023-12-01
• 期刊: The Lancet. Digital health
• 作者: B. Betzler;Haichao Chen;Ching;Cecilia S. Lee;Guochen Ning;Su Jeong Song;Aaron Y. Lee;Ryo Kawasaki;Peter van Wijngaarden;Andrzej Grzybowski;Mingguang He;Dawei Li;An Ran Ran;D. Ting;K. Teo;Paisan Ruamviboonsuk;S. Sivaprasad;V. Chaudhary;R. Tadayoni;Xiaofei Wang;Carol Y Cheung;Yingfeng Zheng;Y. X. Wang;Y. Tham;T. Y. Wong
• 通讯作者: T. Y. Wong